Synthesis and biological activities of novel mitochondria-targeted artemisinin ester derivatives

Bioorg Med Chem Lett. 2021 May 1:39:127912. doi: 10.1016/j.bmcl.2021.127912. Epub 2021 Mar 7.

Abstract

A series of novel artemisinin ester derivatives were designed and synthesized for targeting mitochondria. Cytotoxicity against SMMC-7721, HepG2, OVCAR3, A549 and J82 cancer cell lines was evaluated. Compound 2c (IC50 = 3.0 μM) was the most potent anti-proliferative molecule against the OVCAR3 cells with low cytotoxicity in normal HUVEC cells. The mechanism of action of compound 2c was further investigated by analyzing cell apoptosis, mitochondrial membrane potential (Δψm) and intracellular ROS generation. The results indicated that compound 2c targeted mitochondria and induced cell apoptosis. ROS and heme attributed to the cytotoxicity and cell apoptosis of compound 2c. These promising findings indicated the compound 2c could serve as a great candidate against ovarian cancer for further investigation.

Keywords: Antitumor; Apoptosis; Novel artemisinin ester derivatives; ROS; Δψm.

MeSH terms

  • Antineoplastic Agents / chemical synthesis
  • Antineoplastic Agents / chemistry
  • Antineoplastic Agents / pharmacology*
  • Apoptosis / drug effects
  • Artemisinins / chemical synthesis
  • Artemisinins / chemistry
  • Artemisinins / pharmacology*
  • Cell Line, Tumor
  • Cell Proliferation / drug effects
  • Dose-Response Relationship, Drug
  • Drug Screening Assays, Antitumor
  • Esters / chemical synthesis
  • Esters / chemistry
  • Esters / pharmacology*
  • Humans
  • Mitochondria / drug effects*
  • Mitochondria / metabolism
  • Molecular Structure
  • Reactive Oxygen Species / metabolism
  • Structure-Activity Relationship

Substances

  • Antineoplastic Agents
  • Artemisinins
  • Esters
  • Reactive Oxygen Species